A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood

Journal of Clinical Microbiology

Volumn 34, Issue 5, 1996, Pages 1166-1170

  Grundy, J E ^a   Ehrnst, A ^c,d   Einsele, H ^b   Emery, V C ^a   Hebart, H ^b   Prentice, H G ^a   Ljungman, P ^d  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Ctrl Microbiological Lab SCC   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; VIRUS DETECTION;

EID: 0029866360     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.5.1166-1170.1996     Document Type: Article

References (19)

1. Bootman, J. S., and P. A. Kitchin. 1992. An international collaborative study to assess a set of reference reagents for HIV-1 PCR. J. Virol. Methods 37:23-42.
2. Chou, S. 1992. Effect of interstrain variation on diagnostic DNA amplification of the cytomegalovirus major immediate-early gene region. J. Clin Microbiol. 30:2307-2310.
3. Darlington, J., M. Super, K. Patel, J. E. Grundy, P. D. Griffiths, and V. C. Emery. 1991. Use of polymerase chain reaction to analyse sequence variation within a major neutralising epitope of glycoprotein B (gp58) in clinkal isolates of human cytomegalovirus. J. Gen. Virol 72:1985-1989
4. Ehrnst, A., L. Barkholt, C. Brattstrom, J. Czajkowski, O. Teodosiu, and P. Ljungman. 1993 Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease. J. Med. Virol. 39:118-124.
5. Ehrnst, A., L. Barkhalt, I. Lewensohn-Fuchs, P. Ljungman, O. Teodosiu, A. Staland, O. Ringden, G. Tyden, and B. Johansson. 1995. CMV PCR monitoring in leucocytes of transplant patients. Clin. Diagn. Virol. 3:139-153.
6. Einsele, H., G. Ehninger, M. Steidle, A. Vollbracht, M. Muller, H. Schmidt, J. G. Saal, H. D. Waller, and C. A. Muller. 1991. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 338:1170-1172
7. Einsele, H., M. Steidle, A. Vallbracht, J. G. Saal, G. Ehninger, and C. A. Muller. 1991. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 77:1104-1110.
8. 65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J. Gen. Virol. 73:2923-2932
9. Holodniy, M., S. Kim, D. Katzenstein, M. Konrad, E. Groves, and T. C. Merigan. 1991. Inhibition of human immunodeficiency virus gene amplification by heparin. J. Clin. Microbiol. 29:676-679.
10. Jackson, J. B., J. Drew, H. J. Lin, P. Otto, J. W. Bremer, F. B. Hollinger, S. M. Wolinsky, the ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. 1993. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. J. Clin. Microbiol. 31:3123-3128
11. Kidd, I. M., J. C. Fox, D. Pillay, H. Charman, P. D. Griffiths, and V. C. Emery. 1994. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation 56:867-871.
12. Ljungman, P., J. Aschan, J. N. Azinge, L. Brandt, A. Ehrnst, V. Hammarstrom, A. Linde, B. Lonnqvist, O. Ringden, et al. 1993. Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation. Br. J. Haematol. 83:118-124.
13. Ljungman, P., R. de Bock, C. Cordonnier, H. Einsele, D. Engelhard, J. E. Grundy, A. Luciasculli, P. Reusser, and P. Ribaud. 1993. Practices for cytomegalovirus diagnosis, prophylaxis, and treatment: a report from the working party for infectious diseases within the EBMT. Bone Marrow Transplant. 12:399-403.
14. Meyers, J. D., P. Ljungman, and L. D. Fisher. 1990. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation importance of cytomegalovirus viremia. J. Infect. Dis. 162:373-380.
15. Porter-Jordan, K., E. I Rosenberg, J. F. Keiser, J. D. Gross, A. M. Ross, S. Nasim, and C. T. Garrett. 1990. Nested polymerase chain reaction assay for the detection of cytomegalovirus overcomes false positives caused by contamination with fragmented DNA. J. Med. Virol. 30:85-91.
16. Satsangi, J., D. P. Jewell, K. Welsh, M. Bunce, and J. Bell. 1994. Effect of heparm on polymerase chain reaction. Lancet 343:1509-1510
17. van der Bij, W., J. Schirm, R. Torensma, W. J. van Son, A. M. Tegzess, and T. H. The. 1988. Comparison between viremia and antigcnemia for detection of cytomegalovirus in blood. J. Clin. Microbiol. 26:2531-2535.
18. Willems, M., H. Moshage, F. Nevens, J. Fevery, and S. II. Yap. 1993. Plasma collected from hepariniscd blood is not suitable for HCV-RNA detection by conventional RT-PCR J. Virol. Methods 42:127-130.
19. Zaaijer, H. L., H. T. M. Cuypers, H. W. Reesink, I. N. Winkel, G. Gerken. and P. N. I Lelie. 1993. Reliability of polyrnerase chain reaction for detection of hepatitis C virus Lancet 341:722-724.